Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
58
CINF Quote, Financials, Valuation and Earnings
Last price:
$150.50
Seasonality move
:
2.07%
Day range:
$149.81 - $151.60
52-week range:
$111.92 - $161.75
Dividend yield:
2.19%
P/E ratio:
16.46x
P/S ratio:
2.17x
P/B ratio:
1.72x
Volume:
462.2K
Avg. volume:
677.9K
1-year change:
25.73%
Market cap:
$23.6B
Revenue:
$11.3B
EPS (TTM):
$9.17
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.5B | $9.6B | $6.6B | $10B | $11.3B | |
| Revenue Growth (YoY) | -4.9% | 27.73% | -31.82% | 52.57% | 13.22% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $10M | $10M | $10M | $13M | $15M | |
| Operating Expenses | $20M | $20M | $23M | $25M | $32M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $54M | $53M | $53M | $54M | $53M | |
| EBT. Incl. Unusual Items | $1.5B | $3.7B | -$694M | $2.3B | $2.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $283M | $730M | -$207M | $433M | $566M | |
| Net Income to Company | $1.2B | $3B | -$487M | $1.8B | $2.3B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.2B | $3B | -$487M | $1.8B | $2.3B | |
| Basic EPS (Cont. Ops) | $7.55 | $18.43 | -$3.06 | $11.74 | $14.65 | |
| Diluted EPS (Cont. Ops) | $7.49 | $18.24 | -$3.06 | $11.66 | $14.53 | |
| Weighted Average Basic Share | $161.2M | $161M | $158.8M | $157M | $156.4M | |
| Weighted Average Diluted Share | $162.4M | $162.7M | $158.8M | $158.1M | $157.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.6B | $3.8B | -$641M | $2.3B | $2.9B | |
| Revenue (Reported) | $7.5B | $9.6B | $6.6B | $10B | $11.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.6B | $3.8B | -$641M | $2.3B | $2.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $1.2B | $2.2B | $2.9B | $2.6B | |
| Revenue Growth (YoY) | -- | -45.31% | 83.99% | 30.97% | -12.57% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $2M | $2M | $3M | $3M | $4M | |
| Operating Expenses | $4M | $4M | $5M | $4M | $11M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $13M | $13M | $14M | $13M | $13M | |
| EBT. Incl. Unusual Items | $768M | -$351M | $268M | $953M | -$128M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $148M | -$85M | $43M | $198M | -$38M | |
| Net Income to Company | $620M | -$266M | $225M | $755M | -$90M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $620M | -$266M | $225M | $755M | -$90M | |
| Basic EPS (Cont. Ops) | $3.85 | -$1.66 | $1.43 | $4.82 | -$0.57 | |
| Diluted EPS (Cont. Ops) | $3.82 | -$1.66 | $1.42 | $4.78 | -$0.57 | |
| Weighted Average Basic Share | $161M | $160.4M | $157.2M | $156.8M | $156.4M | |
| Weighted Average Diluted Share | $162.5M | $160.4M | $158.5M | $157.9M | $156.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $781M | -$338M | $282M | $966M | -$115M | |
| Revenue (Reported) | $2.2B | $1.2B | $2.2B | $2.9B | $2.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $781M | -$338M | $282M | $966M | -$115M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9B | $8.6B | $7.6B | $10.7B | $11B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $10M | $10M | $11M | $13M | $16M | |
| Operating Expenses | $19M | $20M | $24M | $24M | $39M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $54M | $53M | $54M | $53M | $53M | |
| EBT. Incl. Unusual Items | $3.8B | $2.6B | -$75M | $3B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $781M | $497M | -$79M | $588M | $330M | |
| Net Income to Company | $3.1B | $2.1B | $4M | $2.4B | $1.4B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.1B | $2.1B | $4M | $2.4B | $1.4B | |
| Basic EPS (Cont. Ops) | $19.03 | $12.79 | $0.12 | $15.13 | $9.26 | |
| Diluted EPS (Cont. Ops) | $18.91 | $12.63 | $0.07 | $15.03 | $9.17 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.9B | $2.6B | -$21M | $3B | $1.8B | |
| Revenue (Reported) | $9.9B | $8.6B | $7.6B | $10.7B | $11B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.9B | $2.6B | -$21M | $3B | $1.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $1.2B | $2.2B | $2.9B | $2.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $2M | $2M | $3M | $3M | $4M | |
| Operating Expenses | $4M | $4M | $5M | $4M | $11M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $13M | $13M | $14M | $13M | $13M | |
| EBT. Incl. Unusual Items | $768M | -$351M | $268M | $953M | -$128M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $148M | -$85M | $43M | $198M | -$38M | |
| Net Income to Company | $620M | -$266M | $225M | $755M | -$90M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $620M | -$266M | $225M | $755M | -$90M | |
| Basic EPS (Cont. Ops) | $3.85 | -$1.66 | $1.43 | $4.82 | -$0.57 | |
| Diluted EPS (Cont. Ops) | $3.82 | -$1.66 | $1.42 | $4.78 | -$0.57 | |
| Weighted Average Basic Share | $161M | $160.4M | $157.2M | $156.8M | $156.4M | |
| Weighted Average Diluted Share | $162.5M | $160.4M | $158.5M | $157.9M | $156.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $781M | -$338M | $282M | $966M | -$115M | |
| Revenue (Reported) | $2.2B | $1.2B | $2.2B | $2.9B | $2.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $781M | -$338M | $282M | $966M | -$115M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $900M | $1.1B | $1.3B | $907M | $983M | |
| Short Term Investments | $12.3B | $13B | $12.1B | $13.8B | $16.5B | |
| Accounts Receivable, Net | $2.4B | $2.6B | $3B | $3.2B | $3.5B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $65M | $78M | $51M | $55M | $70M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $15.9B | $17.1B | $16.7B | $18.3B | $21.4B | |
| Property Plant And Equipment | $213M | $205M | $202M | $208M | $214M | |
| Long-Term Investments | $21.2B | $24.3B | $22B | $24.8B | $27.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $27.5B | $31.4B | $29.7B | $32.8B | $36.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $54M | $54M | $50M | $25M | $25M | |
| Long-Term Debt | $788M | $789M | $789M | $790M | $790M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.8B | $18.3B | $19.2B | $20.7B | $22.6B | |
| Common Stock | $397M | $397M | $397M | $397M | $397M | |
| Other Common Equity Adj | $769M | $648M | -$614M | -$435M | -$309M | |
| Common Equity | $10.8B | $13.1B | $10.6B | $12.1B | $13.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $10.8B | $13.1B | $10.6B | $12.1B | $13.9B | |
| Total Liabilities and Equity | $27.5B | $31.4B | $29.7B | $32.8B | $36.5B | |
| Cash and Short Terms | $13.2B | $14.2B | $13.4B | $14.7B | $17.5B | |
| Total Debt | $842M | $843M | $839M | $815M | $815M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $947M | $987M | $955M | $619M | $1B | |
| Short Term Investments | $12.3B | $12.4B | $12.7B | $963M | $1.2B | |
| Accounts Receivable, Net | $2.6B | $2.8B | $3.2B | $3.4B | $4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $68M | $79M | $57M | $77M | $93M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $16.1B | $16.5B | $17.2B | $5.4B | $6.6B | |
| Property Plant And Equipment | $213M | $203M | $199M | $211M | $216M | |
| Long-Term Investments | $21.7B | $23.1B | $22.6B | $25.6B | $27.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $28.3B | $30.3B | $30.5B | $33.7B | $37.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $57M | $49M | $50M | $25M | $25M | |
| Long-Term Debt | $848M | $841M | $789M | $848M | $790M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $17.2B | $18.2B | $19.7B | $21.1B | $23.6B | |
| Common Stock | $397M | $397M | $397M | $397M | $397M | |
| Other Common Equity Adj | $625M | $59M | -$527M | -$442M | -$271M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $11.1B | $12.1B | $10.7B | $12.7B | $13.7B | |
| Total Liabilities and Equity | $28.3B | $30.3B | $30.5B | $33.7B | $37.3B | |
| Cash and Short Terms | $13.3B | $13.4B | $13.6B | $1.6B | $2.2B | |
| Total Debt | $905M | $890M | $839M | $873M | $815M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.2B | $3B | -$487M | $1.8B | $2.3B | |
| Depreciation & Amoritzation | $109M | $118M | $127M | $112M | $130M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$23M | -$240M | -$340M | -$264M | -$266M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.5B | $2B | $2.1B | $2.1B | $2.6B | |
| Capital Expenditures | $20M | $15M | $15M | $18M | $22M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$560M | -$1.1B | -$933M | -$1.6B | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$375M | -$395M | -$423M | -$454M | -$490M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$261M | -$144M | -$410M | -$67M | -$126M | |
| Other Financing Activities | -$184M | -$159M | -$167M | -$264M | -$271M | |
| Cash From Financing | -$798M | -$685M | -$994M | -$801M | -$877M | |
| Beginning Cash (CF) | $767M | $900M | $1.1B | $1.3B | $907M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $133M | $239M | $125M | -$357M | $76M | |
| Ending Cash (CF) | $900M | $1.1B | $1.3B | $907M | $983M | |
| Levered Free Cash Flow | $1.5B | $2B | $2B | $2B | $2.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $620M | -$266M | $225M | $755M | -$90M | |
| Depreciation & Amoritzation | $23M | $37M | $40M | $34M | $47M | |
| Stock-Based Compensation | $9M | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$164M | -$182M | -$229M | -$203M | -$502M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $354M | $198M | $250M | $353M | $310M | |
| Capital Expenditures | $5M | $4M | $4M | $7M | $3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$153M | -$162M | -$362M | -$355M | -$58M | |
| Dividends Paid (Ex Special Dividend) | -$95M | -$99M | -$106M | -$116M | -$125M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$28M | -$45M | -$25M | -$75M | -$42M | |
| Other Financing Activities | -$38M | -$43M | -$71M | -$98M | -$62M | |
| Cash From Financing | -$154M | -$188M | -$197M | -$286M | -$225M | |
| Beginning Cash (CF) | $900M | $1.1B | $1.3B | $907M | $983M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $47M | -$152M | -$309M | -$288M | $27M | |
| Ending Cash (CF) | $947M | $987M | $955M | $619M | $1B | |
| Levered Free Cash Flow | $349M | $194M | $246M | $346M | $307M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.1B | $2.1B | $4M | $2.4B | $1.4B | |
| Depreciation & Amoritzation | $110M | $132M | $130M | $106M | $143M | |
| Stock-Based Compensation | -- | -$9M | -- | -- | -- | |
| Change in Accounts Receivable | -$110M | -$258M | -$387M | -$238M | -$565M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.7B | $1.8B | $2.1B | $2.2B | $2.6B | |
| Capital Expenditures | $21M | $14M | $15M | $21M | $18M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$577M | -$1.1B | -$1.1B | -$1.6B | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$380M | -$399M | -$430M | -$464M | -$499M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$33M | -$161M | -$390M | -$117M | -$93M | |
| Other Financing Activities | -$177M | -$164M | -$195M | -$291M | -$235M | |
| Cash From Financing | -$640M | -$719M | -$1B | -$890M | -$816M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $461M | $40M | -$32M | -$336M | $391M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.7B | $1.8B | $2.1B | $2.1B | $2.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $620M | -$266M | $225M | $755M | -$90M | |
| Depreciation & Amoritzation | $23M | $37M | $40M | $34M | $47M | |
| Stock-Based Compensation | $9M | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$164M | -$182M | -$229M | -$203M | -$502M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $354M | $198M | $250M | $353M | $310M | |
| Capital Expenditures | $5M | $4M | $4M | $7M | $3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$153M | -$162M | -$362M | -$355M | -$58M | |
| Dividends Paid (Ex Special Dividend) | -$95M | -$99M | -$106M | -$116M | -$125M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$28M | -$45M | -$25M | -$75M | -$42M | |
| Other Financing Activities | -$38M | -$43M | -$71M | -$98M | -$62M | |
| Cash From Financing | -$154M | -$188M | -$197M | -$286M | -$225M | |
| Beginning Cash (CF) | $900M | $1.1B | $1.3B | $907M | $983M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $47M | -$152M | -$309M | -$288M | $27M | |
| Ending Cash (CF) | $947M | $987M | $955M | $619M | $1B | |
| Levered Free Cash Flow | $349M | $194M | $246M | $346M | $307M | |
Get CINF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CINF
Sector
P/E ratio
16.46x
11.93x
PEG ratio
0.39x
0.38x
P/B ratio
1.72x
1.07x
Price / LTM sales
2.17x
2.53x
Growth Metrics
CINF
Sector
Revenue growth
-12.57%
5.42%
Earnings growth
-65.87%
3.76%
Revenue (5-year growth)
7.43%
5.15%
Earnings forecast
-$0.61
$0.56
Profitability
CINF
Sector
Profitability FY 2025
--
$137M
Return on invested capital
10.17%
5.33%
Return on assets
4.04%
0.98%
Return on equity
10.82%
9.28%
Earnings Date
Last Earnings Date
Apr
28
Next Earnings Date
Jul
25
Estimated Next Earnings Date
Jul
28
Balance Sheet
CINF
Sector
Total cash
$2.2B
$473M
Short term investments
$16.5B
$233.7M
Total assets
$36.5B
$4B
Long term debt
$815M
$298.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
